Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia

Eur J Intern Med. 2012 Oct;23(7):e171-2. doi: 10.1016/j.ejim.2012.07.005. Epub 2012 Jul 31.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bezafibrate / therapeutic use*
  • Cytokines / drug effects*
  • Drug Synergism
  • Drug Therapy, Combination
  • Fatty Acids, Omega-3 / therapeutic use*
  • Female
  • Humans
  • Hypertriglyceridemia / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Monocytes / drug effects*

Substances

  • Cytokines
  • Fatty Acids, Omega-3
  • Hypolipidemic Agents
  • Bezafibrate